SCHEMBL5330908

SCHEMBL5330908

CC(C=C(Cl)Cl)NC(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 1/20 0.47
LMNA P02545 6/20 0.47
GFER P55789 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
CTRB1 P17538 1/20 0.44
SLC1A2 P43004 1/20 0.44
HDAC1 Q13547 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27562870 0.80 TUBB4A (0.41) GAAALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL948160 0.80 HPGD (0.56) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL13396265 0.80 HPGD (0.56) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL7056333 0.80 HPGD (0.56) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL11292044 0.79 ALDH1A1 (0.50) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL4553590 0.78 NPSR1 (0.68) GAAALDH1A1RAB9ALMNAMEN1
SCHEMBL9815318 0.77 LMNA (0.61) ALDH1A1SMN1; SMN2HPGDRAB9ALMNA
SCHEMBL4689551 0.77 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2HPGDRAB9ALMNA
SCHEMBL4689548 0.77 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2HPGDRAB9ALMNA
SCHEMBL24998749 0.75 MLYCD (0.58) GAAALDH1A1SMN1; SMN2HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007065010-A2 ANTI-ANGIOGENESIS COMPOUNDS HIF BIO, INC. (US) 2007-06-07 WO disclosed
CN-1241188-A Heterocyclylmethyl-substed pyrazol derivs. BAYER AG (DE) 2000-01-12 CN disclosed
EP-0934311-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER AG (DE) 1999-08-11 EP disclosed
WO-1998016507-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO disclosed